论文部分内容阅读
本文回顾性地对比分析了采用自膨式金属内支架术（ＥＭＢＥ）和经内镜逆行胆管内引流术（ＥＲＢＤ）对２０例恶性肝门部胆管梗阻（ＭＨＢＯ）病人的治疗情况。结果：有效减黄率：在ＥＲＢＤ和ＥＭＢＥ组分别为７７．８％和８８．９％；早期合并胆管炎发生率：ＥＲＢＤ和ＥＭＢＥ分别为５５．６％和１１．２％（Ｐ＜０．００１）；支架梗阻和／或晚期胆管炎发生率两组分别为６６．６％和３７．４％（Ｐ＜０．０１）；两组平均生存期分别为：１５９±７６和２５４±８４天（Ｐ＜０．０１）。结论：ＥＭＢＥ治疗ＭＨＢＯ较ＥＲＢＤ疗效好，早期胆管炎发生率低，支架不易阻塞，生存质量高。
This article retrospectively analyzed the treatment of 20 cases of malignant hilar biliary obstruction (MHBO) using self-expanding metal stent (EMBE) and endoscopic retrograde biliary drainage (ERBD). Results: The effective rate of yellow reduction was 77.8% and 88.9% in ERBD and EMBE groups, and the incidence of early cholangitis was 55.6% and 11.2% in ERBD and EMBE, respectively (P<0. 001); The incidence of stent obstruction and/or advanced cholangitis was 66.6% and 37.4% in the two groups respectively (P<0.01); the average survival time of the two groups was 159±76 and 254±84 days respectively. (P<0.01). Conclusion: EMBE is more effective than ERBD in the treatment of MHBO. The incidence of early cholangitis is low, the stent is not easy to block, and the quality of life is high.